Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

Last Close
Jan 21  •  03:12PM ET
48.90
Dollar change
+5.90
Percentage change
13.73
%
Today, 1:01 PMModerna-Merck cancer vaccine's five-year data showing 49% reduced recurrence risk fueled the sharp intraday rally.
IndexS&P 500 P/E- EPS (ttm)-8.06 Insider Own8.54% Shs Outstand391.00M Perf Week23.50%
Market Cap19.11B Forward P/E- EPS next Y-6.73 Insider Trans-0.07% Shs Float357.38M Perf Month58.01%
Enterprise Value15.34B PEG- EPS next Q-2.58 Inst Own69.82% Short Float19.12% Perf Quarter79.53%
Income-3.12B P/S8.56 EPS this Y14.29% Inst Trans-3.98% Short Ratio6.03 Perf Half Y49.42%
Sales2.23B P/B2.05 EPS next Y15.37% ROA-22.31% Short Interest68.32M Perf YTD65.83%
Book/sh23.86 P/C4.24 EPS next 5Y20.42% ROE-29.32% 52W High45.40 7.72% Perf Year43.58%
Cash/sh11.53 P/FCF- EPS past 3/5Y- -42.94% ROIC-31.11% 52W Low22.28 119.50% Perf 3Y-74.53%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-43.99% 121.86% Gross Margin38.93% Volatility7.63% 6.31% Perf 5Y-60.58%
Dividend TTM- EV/Sales6.87 EPS Y/Y TTM-38.95% Oper. Margin-155.15% ATR (14)2.47 Perf 10Y-
Dividend Ex-Date- Quick Ratio3.73 Sales Y/Y TTM-56.00% Profit Margin-139.61% RSI (14)80.35 Recom2.96
Dividend Gr. 3/5Y- - Current Ratio3.93 EPS Q/Q-1673.01% SMA2037.36% Beta1.23 Target Price36.58
Payout- Debt/Eq0.08 Sales Q/Q-45.44% SMA5061.93% Rel Volume1.52 Prev Close43.00
Employees5800 LT Debt/Eq0.07 EarningsNov 06 BMO SMA20075.72% Avg Volume11.33M Price48.90
IPODec 07, 2018 Option/ShortYes / Yes EPS/Sales Surpr.72.79% 10.33% Trades Volume15,223,331 Change13.73%
Date Action Analyst Rating Change Price Target Change
Jan-07-26Resumed UBS Neutral $34
Dec-12-25Initiated Jefferies Hold $30
Mar-13-25Initiated Citigroup Neutral $40
Feb-18-25Downgrade Barclays Overweight → Equal Weight $111 → $45
Jan-29-25Downgrade Goldman Buy → Neutral $99 → $51
Dec-18-24Downgrade Argus Buy → Hold
Dec-10-24Resumed BofA Securities Underperform $41
Nov-19-24Initiated Berenberg Hold $42
Nov-18-24Upgrade HSBC Securities Hold → Buy $58
Nov-15-24Initiated Wolfe Research Underperform $40
Today 02:24PM
01:57PM
12:21PM
10:06AM
05:38AM
06:00PM Loading…
Jan-20-26 06:00PM
04:21PM
03:31PM
10:24AM
06:58AM
06:00AM
Jan-18-26 11:35PM
08:31AM
Jan-17-26 04:30AM
Jan-16-26 12:45PM
08:55AM Loading…
08:55AM
08:06AM
07:07AM
03:56AM
Jan-15-26 08:53AM
08:26AM
Jan-14-26 05:50PM
07:09AM
04:04AM
Jan-13-26 08:21PM
06:18PM
04:43PM
04:35PM
04:30PM
04:27PM
02:57PM Loading…
02:57PM
02:24PM
01:26PM
01:04PM
Jan-12-26 05:14PM
11:27AM
10:24AM
08:51AM
07:00AM
Jan-08-26 05:50PM
Jan-07-26 09:26AM
08:55AM
08:04AM
04:35AM
03:58AM
Jan-06-26 11:12AM
Jan-05-26 06:44AM
Dec-30-25 05:45PM
Dec-27-25 10:30AM
Dec-26-25 02:14PM
01:53PM
12:12PM
10:25AM
10:25AM
Dec-23-25 05:45PM
Dec-22-25 08:55AM
Dec-19-25 03:16PM
10:10AM
04:30AM
Dec-18-25 01:14PM
12:32PM
11:51AM
09:54AM
07:00AM
Dec-17-25 01:01PM
07:00AM
Dec-16-25 09:55AM
03:03AM
Dec-15-25 09:05AM
07:00AM
Dec-12-25 10:47AM
09:35AM
09:13AM
Dec-11-25 02:03PM
12:50PM
07:44AM
Dec-09-25 09:36PM
11:04AM
Dec-08-25 09:30AM
09:30AM
Dec-05-25 02:15PM
Dec-04-25 09:35AM
Dec-03-25 09:01AM
Dec-02-25 09:40AM
08:12AM
07:53AM
06:22AM
04:17AM
Dec-01-25 11:03PM
04:46PM
04:45PM
04:38PM
03:36PM
03:05PM
02:57PM
02:19PM
12:35PM
12:24PM
12:23PM
12:09PM
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AFEYAN NOUBARDirectorDec 11 '25Option Exercise10.9023,853259,99827,777Dec 15 09:00 AM
AFEYAN NOUBARDirectorDec 11 '25Sale29.4823,853703,3063,924Dec 15 09:00 AM
Bancel StephaneChief Executive OfficerDec 11 '25Option Exercise10.90688,0737,499,9966,181,970Dec 15 08:59 AM
Flagship Pioneering Inc.AffiliateDec 11 '25Proposed Sale29.4923,853703,306Dec 11 04:30 PM
Hussain AbbasDirectorDec 09 '25Sale27.6050413,9101,515Dec 11 04:16 PM
Hussain AbbasDirectorDec 09 '25Proposed Sale27.6050413,910Dec 09 10:26 AM
Hussain AbbasDirectorJun 11 '25Sale28.003128,736580Jun 12 04:22 PM
Hussain AbbasDirectorJun 11 '25Proposed Sale28.003128,736Jun 11 10:06 AM
Bancel StephaneChief Executive OfficerMar 03 '25Buy31.22160,3145,004,3189,210,686Mar 04 04:27 PM
SAGAN PAULDirectorMar 03 '25Buy31.7631,6201,004,251312,027Mar 04 04:24 PM